Lb Pharmaceuticals

Developer of small molecule based therapeutics for schizophrenia

placeNew York City, New York, United States calendar_todayFounded 2015 language lbpharma.us

Innovation

7 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 436 times.

YearFilings
20182
20192
20204
20213
20223
20232
20242
20253

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon